Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001104659-24-010797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-05 | 2024-02-01 | RYTM | Meeker David P | Pres, CEO, Dir | M - OptEx | — | +14.1K | 125.5K | +13% | — |
| D | 2024-02-05 | 2024-02-01 | RYTM | Meeker David P | Pres, CEO, Dir | S - Sale+OE | $45.06 | -4,361 | 121.1K | -3% | -$196.5K |
| D | 2024-02-05 | 2024-02-01 | RYTM | Meeker David P | Pres, CEO, Dir | M - OptEx | $0.00 | -14.1K | 42.4K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 14,125 | — | 125,460 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2024-02-01 | S | D | 4,361 | $45.06 | 121,099 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-02-01 | M | D | 14,125 | $0.00 | 42,375 | D | — · — to — | 14,125 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. |